Skip to main content
. 2024 May 15;15:1338683. doi: 10.3389/fendo.2024.1338683

Table 2.

Ovarian stimulation in the patients in each group.

Items Group A Group B Group C Group D χ2/F P value
No. of patients 3038 3228 3436 3172
dosage of Gn (U) 1875 (1425–2400) 2100 (1650–2700) a 2325 (1800–2850) ab 2625 (2100–3150) abc 1198.753 0.000
duration of Gn (d) 10.0 ± 1.6 10.1 ± 1.6 10.2 ± 1.5a 10.3 ± 1.7ab 13.600 0.000
LH on hCG injection day (IU/L) 1.4 (0.9–2.2) 1.8 (1.1–2.8) a 1.9 (1.1–3.1) ab 2.1 (1.2–3.6) abc 454.564 0.000
E2 on hCG injection day (pmol/L) 6834 (5110–9382) 6953 (5167–9963)a 7164 (5270–10235) ab 6498 (4574–9276) abc 90.621 0.000
P on hCG injection day (nom/L) 1.4 (1.1–1.7) 2.1 (1.6–2.5) a 2.6 (2.0–3.3) ab 3.2 (2.4–4.9) abc 5280.862 0.000
P/E2 ratio 0.23 (0.17–0.31) 0.33 (0.24–0.44) a 0.40 (0.31–0.53) ab 0.55 (0.42–0.74) abc 4695.487 0.000
P/O ratio 0.11 (0.09–0.13) 0.18 (0.16–0.20) a 0.26 (0.24–0.29) ab 0.43 (0.37–0.54) abc 12072.402 0.000
Endometrial thickness on hCG day(cm) 10.8 ± 1.4 10.7 ± 1.4 10.6 ± 1.4ab 10.6 ± 1.5ab 18.199 0.000
No. of oocytes retrieved 13 (11–16) 12 (9–14) a 10 (8–13) ab 7 (5–9) abc 3928.658 0.000
MII oocyte rate (%) 76.3 76.6 79.4 ab 81.0ab 118.840 0.000*
ICSI rate (%) 43.9 41.3 41.5 38.4 abc 19.611 0.000*
Available embryo number 4 (3–7) 3 (2–5) a 3 (2–5) ab 2 (2–3) abc 988.474 0.000
Ratio of available embryos to retrieved oocytes (%) 35.9 35.8 36.7 40.9abc 106.512 0.000

a indicates P<0.05 compared with Group A; b indicates P<0.05 compared with Group B; c indicates P<0.05 compared with Group C. * indicates a significant difference between the two groups (P<0.008).